长双歧杆菌
蹒跚学步的孩子
双歧杆菌
结肠炎
合生元
炎症性肠病
肠道菌群
粪便
短双歧杆菌
微生物学
溃疡性结肠炎
生物
食品科学
益生菌
花生四烯酸
微生物群
医学
腹泻
发酵
新陈代谢
作者
Yizhi Jing,Xiaoyue Bai,Junzhu Li,Xin Feng,Yaxin Gu,Yun Seong Ji,Zhengyuan Zhai,Yanling Hao
标识
DOI:10.1021/acs.jafc.6c11011
摘要
Increasing inflammatory bowel disease (IBD) incidence in toddlers requires safe interventions. We developed a synbiotic combining 2'-fucosyllactose (2'-FL) with Bifidobacterium strain and evaluated its protective efficacy against DSS-induced colitis in toddler microbiota-associated (TMA) mice. Among 30 Bifidobacterium strains, Bifidobacterium longum subsp. infantis BXY2 and Bifidobacterium. breve BG4 utilized 2'-FL in vitro. However, only the 2'-FL and BXY2 synbiotic significantly alleviated colitis. The 400 mg/kg 2'-FL and BXY2 synbiotic showed the greatest protective effect, restoring body weight and colon length, reducing disease activity and histological scores, improving barrier function, attenuating inflammation. Compared with 2'-FL or BXY2 alone, the synbiotic enhanced goblet cells and barrier proteins. Metagenomics revealed enrichment of B. longum subsp. infantis and Phascolarctobacterium faecium. Metabolomics showed reduced fecal arachidonic acid (AA). These results indicated that gut microbial AA metabolism might be involved in alleviating colitis in TMA mice. Thus, this synbiotic is a promising preventive strategy for toddler IBD.
科研通智能强力驱动
Strongly Powered by AbleSci AI